Chemistry:Teprenone

Teprenone
Clinical data
Trade names	Selbex
AHFS/Drugs.com	International Drug Names
ATC code	A02BX15 (WHO) QA02BX15 (WHO);
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;
CAS Number	6809-52-5;
PubChem CID	5282199;
DrugBank	DB15955 ;
ChemSpider	29787024;
UNII	S8S8451A4O;
KEGG	D01827 ;
ChEBI	CHEBI:31649;
ChEMBL	ChEMBL79686;
Chemical and physical data
Formula	C23H38O
Molar mass	330.556 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O;
	InChI InChI=1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3/b20-13+,21-15+,22-17+; Key:HUCXKZBETONXFO-NJFMWZAGSA-N;
	(verify)

Short description: Chemical compound

Teprenone (or geranylgeranylacetone), sold under the brand name Selbex,^[1] is a medication used for the treatment of gastric ulcers.^[2]

References

↑ "[Teprenone in the treatment of chronic superficial gastritis, a multicentre study]" (in Chinese). Zhonghua Nei Ke Za Zhi 35 (1): 12–4. January 1996. PMID 9275638.
↑ "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. September 2008. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Teprenone. Read more

v t e Drugs for peptic ulcer and GERD/GORD (A02B)
H₂ antagonists ("-tidine")	Cimetidine Famotidine Lafutidine Lavoltidine (loxtidine) Niperotidine Nizatidine Ranitidine^# Roxatidine
Prostaglandins (E)/analogues ("-prost-")	Misoprostol Enprostil
Proton-pump inhibitors ("-prazole")	Azeloprazole Dexlansoprazole Esomeprazole Ilaprazole Lansoprazole Omeprazole^# Pantoprazole Picoprazole Rabeprazole Tenatoprazole Timoprazole
Potassium-competitive acid blockers ("-prazan")	Linaprazan Revaprazan Soraprazan Vonoprazan
Others	Aceglutamide aluminum Acetoxolone Alginic acid Arbaclofen placarbil Bismuth subcitrate Carbenoxolone Cetraxate Gefarnate Lesogaberan Pirenzepine Proglumide Rebamipide Sucralfate Sulglicotide Telenzepine Teprenone Troxipide Zinc L-carnosine Zolimidine
Combinations	Bismuth subcitrate/metronidazole/tetracycline
See also: Helicobacter pylori* eradication protocols*
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III